THE HPV PROFILE OF PATIENTS WITH OROPHARYNGEAL TUMORS IN AN ONCOLOGY INSTITUTION IN PORTUGAL BETWEEN 2018 AND 2019 – DESCRIPTIVE RETROSPECTIVE STUDY

Abstract

Oropharyngeal cancer is a disease with an increasing incidence, mostly detected in advanced stages. This increase in incidence is currently related to Human Papillomavirus (HPV) infection, associated with changes in the sexual behaviour of the population, in the last decades. This study aimed to characterize the oropharyngeal cancer patients’ profile in Northern Portugal regarding the HPV infection status and to analyse the survival profile of those patients. This descriptive retrospective study included 134 patients with histological confirmation of oropharyngeal cancer and immunohistochemical characterization of HPV status, that were referred to the Head and Neck Department of the Instituto Português de Oncologia do Porto, between January 2018 and December 2019. Most of the oropharyngeal cancer cases were diagnosed in male subjects (91,7%). Interestingly, only 14,6% (18/123) of male cases were HPV-positive, in contrast to 63,6% (7/11) HPV-positive tumours diagnosed in female subjects. Moreover, among all patients integrated into this study, only 18,7% had HPV-positive tumours, and the majority of the referred patients (73,9%) were diagnosed at later stages (stage III or IV). In this study, it was also observed that, in later stages, the number of HPV-negative cases increased and the HPV-positive cases decreased.

Downloads

Download data is not yet available.

References

1. DGS (2014) ‘PORTUGAL Doenças Oncologicas em Números - 2014’, p. 86. Available at: http://www.dgs.pt/estatisticas-de-saude/estatisticas-de-saude/publicacoes/portugal-doencas-oncologicas-em-numeros-2014.aspx.

2. Torre, L. A. et al. (2016) ‘Global cancer incidence and mortality rates and trends - An update’, Cancer Epidemiology Biomarkers and Prevention, 25(1), pp. 16–27. doi: 10.1158/1055-9965.EPI-15-0578.

3. RORENO (2010) Registo Oncológico Nacional 2010. Porto. Available at: https://issuu.com/ipoporto/docs/ro_nacional_2010.

4. Estêvão, R. et al. (2016) ‘Características epidemiológicas e demográficas dos doentes portadores de tumores da cabeça e pescoço no norte de Portugal: Impacto na sobrevivência’, Acta Medica Portuguesa, 29(10), pp. 597–604. doi: 10.20344/amp.7003.

5. Kreimer, A. R. et al. (2005) ‘Human papillomavirus types in head and neck sKreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiology, Biomarkers & Preven’, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 14(2), pp. 467–75. doi: 10.1158/1055-9965.EPI-04-0551.

6. Schache, A. G., Powell, N. and Cuschieri, K. (2016) ‘HPV-related oropharynx cancer in the United Kingdom – an evolution in the understanding of disease etiology’, Cancer Research, 76(22), pp. 6598–6606.

7. Lydiatt, W. M. et al. (2017) ‘Head and Neck Cancers—Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual’, CA: A Cancer Journal for Clinicians, 67(4), pp. 290–303. doi: 10.3322/caac.21393.

8. Warnakulasuriya, S. (2009) ‘Global epidemiology of oral and oropharyngeal cancer’, Oral Oncology. Elsevier Ltd, 45(4–5), pp. 309–316. doi: 10.1016/j.oraloncology.2008.06.002.

9. Mehanna, H. et al. (2012) ‘Prevalence Of Human Papillomavirus In Oropharyngeal And Nonoropharyngeal Head And Neck Cancer—Systematic Review And Meta-Analysis Of Trends By Time And Region’, Wiley Periodicals, Inc. Head Neck. doi: 10.1002/HED.

10. Danaei, G. et al. (2005) ‘Causes of cancer in the world: Comparative risk assessment of nine behavioural and environmental risk factors’, Lancet, 366(9499), pp. 1784–1793. doi: 10.1016/S0140-6736(05)67725-2.

11. Pytynia, K. B., Dahlstrom, K. R. and Sturgis, E. M. (2014) ‘Epidemiology of HPV-associated oropharyngeal cancer’, Oral Oncology. Elsevier Ltd, 50(5), pp. 380–386. doi: 10.1016/j.oraloncology.2013.12.019.

12. Chaturvedi, A. K. et al. (2008) ‘Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States’, Journal of Clinical Oncology, 26(4), pp. 612–619. doi: 10.1200/JCO.2007.14.1713.

13. Heck, J. E. et al. (2009) ‘Sexual behaviours and the risk of head and neck cancers: A pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium’, International Journal of Epidemiology, 39(1), pp. 166–181. doi: 10.1093/ije/dyp350.

14. Ang, K. K. et al. (2010) ‘Human papillomavirus and survival of patients with oropharyngeal cancer’, New England Journal of Medicine, 363(1), pp. 24–35. doi: 10.1056/NEJMoa0912217.

15. Rodriguez-Archilla, A. (2018) ‘Diagnostic Delay in Oral Cancer inical research.’, Annals of Clinical Research and Trials, 2(1).

16. Programa Nacional de Promoção da Saúde Oral (PNPSO) https://www.saudeoral.min-saude.pt/pnpso/public/index.jsp
Published
2021-08-09
How to Cite
VALENTE DE SOUSA, Pedro et al. THE HPV PROFILE OF PATIENTS WITH OROPHARYNGEAL TUMORS IN AN ONCOLOGY INSTITUTION IN PORTUGAL BETWEEN 2018 AND 2019 – DESCRIPTIVE RETROSPECTIVE STUDY. Revista Portuguesa de Cirurgia, [S.l.], n. 50, p. 23-31, aug. 2021. ISSN 2183-1165. Available at: <https://revista.spcir.com/index.php/spcir/article/view/853>. Date accessed: 26 apr. 2024.
Section
Original Papers